prednisolone has been researched along with Atherogenesis in 15 studies
Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To determine the influence of low-dose prednisolone on atherosclerosis, endothelial function, and risk factors for atherosclerosis in patients with early rheumatoid arthritis (RA)." | 9.12 | Effects of low-dose prednisolone on endothelial function, atherosclerosis, and traditional risk factors for atherosclerosis in patients with rheumatoid arthritis--a randomized study. ( Deneberg, S; Frostegård, J; Hafström, I; Jogestrand, T; Rohani, M; Wörnert, M, 2007) |
| "Atherosclerosis is a lipid-driven inflammatory disease, for which nanomedicinal interventions are under evaluation." | 5.43 | Liposomal prednisolone promotes macrophage lipotoxicity in experimental atherosclerosis. ( Alaarg, A; Dallinga-Thie, GM; de Winther, M; Hamers, AA; Laudes, M; Lutgens, E; Meiler, S; Metselaar, JM; Mulder, WJ; Schulte, DM; Seijkens, T; Stroes, ES; Tang, J; Van den Bossche, J; van der Valk, FM; Zheng, KH, 2016) |
| " Our paper details the first clinical studies of a liposomal nanoparticle encapsulating prednisolone (LN-PLP) in atherosclerosis." | 5.20 | Prednisolone-containing liposomes accumulate in human atherosclerotic macrophages upon intravenous administration. ( Calcagno, C; Dallinga-Thie, GM; Fayad, ZA; Legemate, DA; Lobatto, ME; Mani, V; Metselaar, JM; Mulder, WJ; Nederveen, AJ; Nieuwdorp, M; Otten, MJ; Paridaans, MP; Ramachandran, S; Schulte, DM; Storm, G; Stroes, ES; van der Valk, FM; van Wijk, DF; Verberne, HJ; Willems, MC, 2015) |
| "To determine the influence of low-dose prednisolone on atherosclerosis, endothelial function, and risk factors for atherosclerosis in patients with early rheumatoid arthritis (RA)." | 5.12 | Effects of low-dose prednisolone on endothelial function, atherosclerosis, and traditional risk factors for atherosclerosis in patients with rheumatoid arthritis--a randomized study. ( Deneberg, S; Frostegård, J; Hafström, I; Jogestrand, T; Rohani, M; Wörnert, M, 2007) |
| "Atherosclerosis is a lipid-driven inflammatory disease, for which nanomedicinal interventions are under evaluation." | 1.43 | Liposomal prednisolone promotes macrophage lipotoxicity in experimental atherosclerosis. ( Alaarg, A; Dallinga-Thie, GM; de Winther, M; Hamers, AA; Laudes, M; Lutgens, E; Meiler, S; Metselaar, JM; Mulder, WJ; Schulte, DM; Seijkens, T; Stroes, ES; Tang, J; Van den Bossche, J; van der Valk, FM; Zheng, KH, 2016) |
| "We report a patient with systemic lupus erythematosus (SLE) who developed progressive emaciation and postprandial abdominal pain with a 27-year history of corticosteroid treatment." | 1.36 | Intestinal angina due to atherosclerosis in a 45-year-old systemic lupus erythematosus patient. ( Fukui, D; Ikeda, S; Kurozumi, M; Matsuda, M; Miyazaki, D; Sano, K; Shimojima, Y; Tazawa, K; Tojo, K, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (6.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (20.00) | 29.6817 |
| 2010's | 9 (60.00) | 24.3611 |
| 2020's | 2 (13.33) | 2.80 |
| Authors | Studies |
|---|---|
| Shimizu, N | 1 |
| Ngayama, D | 1 |
| Watanabe, Y | 1 |
| Yamaguchi, T | 1 |
| Nakamura, S | 1 |
| Ohira, M | 1 |
| Saiki, A | 1 |
| Onda, H | 1 |
| Yamaoka, S | 1 |
| Abe, K | 1 |
| Nakaseko, C | 1 |
| Tatsuno, I | 1 |
| Saito, M | 1 |
| Yajima, N | 1 |
| Yanai, R | 1 |
| Tsubokura, Y | 1 |
| Ichinose, K | 1 |
| Yoshimi, R | 1 |
| Ohno, S | 1 |
| Sada, KE | 1 |
| Souza, AW | 1 |
| de Leeuw, K | 1 |
| van Timmeren, MM | 1 |
| Limburg, PC | 1 |
| Stegeman, CA | 1 |
| Bijl, M | 1 |
| Westra, J | 1 |
| Kallenberg, CG | 1 |
| Lobatto, ME | 2 |
| Calcagno, C | 2 |
| Otten, MJ | 2 |
| Millon, A | 1 |
| Ramachandran, S | 2 |
| Paridaans, MP | 2 |
| van der Valk, FM | 4 |
| Storm, G | 3 |
| Stroes, ES | 4 |
| Fayad, ZA | 2 |
| Mulder, WJ | 3 |
| Metselaar, JM | 4 |
| van Wijk, DF | 1 |
| Verberne, HJ | 1 |
| Willems, MC | 1 |
| Legemate, DA | 1 |
| Nederveen, AJ | 1 |
| Mani, V | 1 |
| Dallinga-Thie, GM | 2 |
| Nieuwdorp, M | 1 |
| Schulte, DM | 3 |
| Meiler, S | 1 |
| Tang, J | 1 |
| Zheng, KH | 2 |
| Van den Bossche, J | 1 |
| Seijkens, T | 1 |
| Laudes, M | 1 |
| de Winther, M | 1 |
| Lutgens, E | 1 |
| Alaarg, A | 2 |
| Hamers, AA | 2 |
| da Silva, AE | 1 |
| Versloot, M | 1 |
| van Ufford, LC | 1 |
| Arida, A | 1 |
| Protogerou, AD | 1 |
| Konstantonis, G | 1 |
| Fragiadaki, K | 1 |
| Kitas, GD | 1 |
| Sfikakis, PP | 1 |
| Joner, M | 1 |
| Morimoto, K | 1 |
| Kasukawa, H | 1 |
| Steigerwald, K | 1 |
| Merl, S | 1 |
| Nakazawa, G | 1 |
| John, MC | 1 |
| Finn, AV | 1 |
| Acampado, E | 1 |
| Kolodgie, FD | 1 |
| Gold, HK | 1 |
| Virmani, R | 1 |
| Sarembock, IJ | 1 |
| Vettori, S | 1 |
| Maresca, L | 1 |
| Cuomo, G | 1 |
| Abbadessa, S | 1 |
| Leonardo, G | 1 |
| Valentini, G | 1 |
| Matsuda, M | 1 |
| Miyazaki, D | 1 |
| Tojo, K | 1 |
| Tazawa, K | 1 |
| Shimojima, Y | 1 |
| Kurozumi, M | 1 |
| Fukui, D | 1 |
| Sano, K | 1 |
| Ikeda, S | 1 |
| Moll, R | 1 |
| Hameed, B | 1 |
| CONSTANTINIDES, P | 1 |
| HOSPES, D | 1 |
| WILLIAMS, K | 1 |
| Hafström, I | 1 |
| Rohani, M | 1 |
| Deneberg, S | 1 |
| Wörnert, M | 1 |
| Jogestrand, T | 1 |
| Frostegård, J | 1 |
2 trials available for prednisolone and Atherogenesis
| Article | Year |
|---|---|
Prednisolone-containing liposomes accumulate in human atherosclerotic macrophages upon intravenous administration.
Topics: Administration, Intravenous; Adult; Aged; Anti-Inflammatory Agents; Arteries; Atherosclerosis; Femal | 2015 |
Effects of low-dose prednisolone on endothelial function, atherosclerosis, and traditional risk factors for atherosclerosis in patients with rheumatoid arthritis--a randomized study.
Topics: Adult; Aged; Aged, 80 and over; Antirheumatic Agents; Arthritis, Rheumatoid; Atherosclerosis; Caroti | 2007 |
13 other studies available for prednisolone and Atherogenesis
| Article | Year |
|---|---|
Rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone (R-CHOP) therapy increases carotid intima-media thickness and plaque score with von Willebrand factor activity elevation in patients with malignant lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Atherosclerosis; Carotid Intima-Media Thickness; Cyc | 2022 |
Prevalence and treatment conditions for hypertension and dyslipidaemia complicated with systemic lupus erythematosus: A multi-centre cross-sectional study.
Topics: Adult; Atherosclerosis; Cohort Studies; Cross-Sectional Studies; Dyslipidemias; Female; Glucocortico | 2021 |
Impact of serum high mobility group box 1 and soluble receptor for advanced glycation end-products on subclinical atherosclerosis in patients with granulomatosis with polyangiitis.
Topics: Atherosclerosis; Atorvastatin; Female; Granulomatosis with Polyangiitis; Heptanoic Acids; HMGB1 Prot | 2014 |
Pharmaceutical development and preclinical evaluation of a GMP-grade anti-inflammatory nanotherapy.
Topics: Animals; Anti-Inflammatory Agents; Aorta; Atherosclerosis; Chemistry, Pharmaceutical; Glucocorticoid | 2015 |
Liposomal prednisolone promotes macrophage lipotoxicity in experimental atherosclerosis.
Topics: Animals; Atherosclerosis; Humans; Liposomes; Macrophages; Mice; Plaque, Atherosclerotic; Prednisolon | 2016 |
Multiple pathway assessment to predict anti-atherogenic efficacy of drugs targeting macrophages in atherosclerotic plaques.
Topics: Animals; Anti-Inflammatory Agents; Atherosclerosis; Cell Proliferation; Cytokines; Endoplasmic Retic | 2016 |
Atherosclerosis is not accelerated in rheumatoid arthritis of low activity or remission, regardless of antirheumatic treatment modalities.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Atherosclerosis; Biological Factors; Carotid Artery Dis | 2017 |
Site-specific targeting of nanoparticle prednisolone reduces in-stent restenosis in a rabbit model of established atheroma.
Topics: Angioplasty, Balloon; Animals; Anti-Inflammatory Agents; Atherosclerosis; Benzamidines; Cell Prolife | 2008 |
From systemic shotgun to site-specific nanoparticle-targeted delivery: a new paradigm for drug delivery.
Topics: Angioplasty, Balloon; Animals; Anti-Inflammatory Agents; Atherosclerosis; Benzamidines; Cell Prolife | 2008 |
Clinical and subclinical atherosclerosis in systemic sclerosis: consequences of previous corticosteroid treatment.
Topics: Adrenal Cortex Hormones; Adult; Atherosclerosis; Carotid Artery Diseases; Collagen Type III; E-Selec | 2010 |
Intestinal angina due to atherosclerosis in a 45-year-old systemic lupus erythematosus patient.
Topics: Abdominal Pain; Aorta, Abdominal; Atherosclerosis; Humans; Intestines; Ischemia; Lupus Erythematosus | 2010 |
A case of Takayasu arteritis diagnosed at early-phase of disease by conventional CT scanning.
Topics: Adult; Aorta; Aortitis; Atherosclerosis; Azathioprine; Behcet Syndrome; Diagnosis, Differential; Dos | 2012 |
Estriol and prednisolone in rabbit atherosclerosis.
Topics: Animals; Arteriosclerosis; Atherosclerosis; Contraceptive Agents, Female; Estradiol Congeners; Estri | 1962 |